• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The natural history of hepatocellular carcinoma. A study of 100 untreated cases.

作者信息

Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K

出版信息

Cancer. 1984 Oct 1;54(7):1461-5. doi: 10.1002/1097-0142(19841001)54:7<1461::aid-cncr2820540740>3.0.co;2-7.

DOI:10.1002/1097-0142(19841001)54:7<1461::aid-cncr2820540740>3.0.co;2-7
PMID:6205743
Abstract

The natural course of hepatocellular carcinoma (HCC) was evaluated in 100 untreated patients who were seen during recent 13 years. There were 80 males and 20 females. The macroscopic type of tumor was massive in 58, nodular in 35, and diffuse in 7 cases. Liver cirrhosis was associated with in 80% of patients. The mean survival time of overall patients was 4 months from the onset of initial symptoms to death and 2 months from admission to death. Occult and cirrhotic types of HCC showed a longer survival than frank and febrile types that had a mean survival time of all patients. The prognosis of icteric and metastatic types was poorest. Sex, tumor type, or associated cirrhosis did not substantially affect the natural course of HCC. The tumor stage and clinical stage were grossly correlated to the prognosis. In terms of symptoms, severe jaundice and ascites were the most dismal prognostic signs.

摘要

相似文献

1
The natural history of hepatocellular carcinoma. A study of 100 untreated cases.
Cancer. 1984 Oct 1;54(7):1461-5. doi: 10.1002/1097-0142(19841001)54:7<1461::aid-cncr2820540740>3.0.co;2-7.
2
The natural history of primary liver cell carcinoma: a study of 89 untreated adult Nigerians.原发性肝细胞癌的自然病史:对89名未经治疗的成年尼日利亚人的研究。
Cent Afr J Med. 1992 Jan;38(1):25-30.
3
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.原发性胆汁性肝硬化中的肝细胞癌及其对预后的影响。
Hepatology. 1997 Nov;26(5):1138-42. doi: 10.1002/hep.510260508.
4
The development of hepatocellular carcinoma from liver cirrhosis during a follow-up study.在一项随访研究中,肝硬化发展为肝细胞癌的情况。
Gastroenterol Jpn. 1989 Oct;24(5):567-72. doi: 10.1007/BF02773887.
5
Impaired phosphate and tension homologue deleted on chromosome 10 expression and its prognostic role in radical surgery for hepatocellular carcinoma with family aggregation resulting from hepatitis B and liver cirrhosis.10 号染色体缺失张力同源物表达异常及其在乙型肝炎和肝硬化家族聚集所致肝癌根治性手术中的预后作用。
Exp Biol Med (Maywood). 2013 Aug 1;238(8):866-73. doi: 10.1177/1535370213494654. Epub 2013 Jul 4.
6
[Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].[德国的肝细胞癌。一所大学诊所100例连续患者的流行病学、病因、临床情况及预后]
Z Gastroenterol. 1997 Dec;35(12):1059-67.
7
Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma.血清玻连蛋白在乙型肝炎相关肝细胞癌中的诊断和预后作用
Cancer Biomark. 2016 Sep 26;17(3):271-279. doi: 10.3233/CBM-160639.
8
Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.肿瘤坏死因子β +252多态性与慢性乙型和丙型肝炎病毒感染在肝细胞癌风险和预后方面的独立及相加相互作用:一项病例对照研究
Asian Pac J Cancer Prev. 2014;15(23):10209-15. doi: 10.7314/apjcp.2014.15.23.10209.
9
Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.对肝细胞癌患者肝硬化肝细胞进行流式细胞术DNA分析可提供一种新的预后因素。
Cancer. 1996 Sep 15;78(6):1195-202. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1195::AID-CNCR5>3.0.CO;2-9.
10
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.经皮乙醇注射治疗后代偿期肝硬化合并小肝细胞癌患者生存的预后因素
Cancer. 2001 Jul 1;92(1):126-35. doi: 10.1002/1097-0142(20010701)92:1<126::aid-cncr1300>3.0.co;2-v.

引用本文的文献

1
Hepatocellular carcinoma tumor thrombus entering the right atrium treated with combining percutaneous and intravenous high-dose-rate brachytherapy: a case report.经皮与静脉高剂量率近距离放疗联合治疗进入右心房的肝细胞癌肿瘤血栓:一例报告
CVIR Endovasc. 2021 Oct 7;4(1):71. doi: 10.1186/s42155-021-00259-x.
2
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study.开发和验证一种个体化预测肝癌手术后 6 个月内术后死亡率的计算器:一项国际多中心研究。
Hepatol Int. 2021 Apr;15(2):459-471. doi: 10.1007/s12072-021-10140-7. Epub 2021 Feb 3.
3
Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
质子束治疗合并下腔静脉癌栓的肝细胞癌。
J Cancer Res Clin Oncol. 2020 Mar;146(3):711-720. doi: 10.1007/s00432-019-03096-7. Epub 2019 Nov 27.
4
Proton Beam Therapy for Hepatocellular Carcinoma: A Review of the University of Tsukuba Experience.质子束疗法治疗肝细胞癌:筑波大学经验综述
Int J Part Ther. 2016 Mar;2(4):570-578. doi: 10.14338/IJPT-15-00035.2. Epub 2016 Mar 24.
5
Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus.立体定向体部放疗作为伴有广泛下腔静脉及心房肿瘤血栓的肝细胞癌的初始治疗方法。
Onco Targets Ther. 2019 Jul 4;12:5299-5303. doi: 10.2147/OTT.S208560. eCollection 2019.
6
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma.肝细胞癌患者下腔静脉肿瘤血栓的放射治疗。
BMC Cancer. 2019 Jun 10;19(1):560. doi: 10.1186/s12885-019-5654-9.
7
Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials.肝细胞癌外照射放疗手册:适应症、证据及临床试验综述
Onco Targets Ther. 2018 May 16;11:2865-2874. doi: 10.2147/OTT.S164651. eCollection 2018.
8
The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.拉米夫定治疗对合并晚期肝细胞癌的乙型肝炎病毒相关性肝硬化患者接受肝动脉灌注化疗的重要性。
Clin Cancer Drugs. 2015 Feb;2(2):112-118. doi: 10.2174/2212697X02666150602220735.
9
Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma.淋巴管内皮透明质酸受体-1是人类肝细胞癌的一种新型预后指标。
Mol Clin Oncol. 2013 Nov;1(6):1039-1048. doi: 10.3892/mco.2013.167. Epub 2013 Aug 6.
10
Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review).肝动脉灌注化疗治疗晚期肝细胞癌的毒性与疗效(综述)
Oncol Lett. 2012 Feb;3(2):259-263. doi: 10.3892/ol.2011.469. Epub 2011 Nov 2.